8β-VE2

Synthetic estrogen
| 8β-VE2
| |
|---|---|
| Synonyms | 8β-Vinylestradiol |
| Chemical nomenclature | |
| IUPAC name | (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol
|
| Identifiers | |
| CAS Number | 123456-78-9
|
| Chemical data | |
| Chemical formula | C_18H_24O_2
|
| Molecular weight | 272.38
|
8β-VE2 (8β-Vinylestradiol) is a synthetic estrogen and a derivative of estradiol. It is characterized by the presence of a vinyl group at the 8β position of the estradiol molecule. This modification alters its pharmacokinetics and pharmacodynamics compared to natural estradiol.
Chemical Structure[edit]
8β-VE2 has the chemical formula C_18H_24O_2 and a molecular weight of 272.38 g/mol. The IUPAC name for 8β-VE2 is (8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol.
Pharmacology[edit]
8β-VE2 acts as an agonist of the estrogen receptors, similar to estradiol. However, the presence of the vinyl group at the 8β position may influence its binding affinity and activity at the receptor level. This can result in different pharmacokinetic and pharmacodynamic properties compared to natural estradiol.
Uses[edit]
8β-VE2 is primarily used in research settings to study the effects of modified estrogens on various biological systems. It is not commonly used in clinical practice.
Synthesis[edit]
The synthesis of 8β-VE2 involves the chemical modification of estradiol to introduce a vinyl group at the 8β position. This process typically requires several steps, including protection and deprotection of functional groups, as well as selective reactions to achieve the desired modification.
Related Compounds[edit]
See Also[edit]
References[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian